TRXF11 just announced a new share issue — what happens to my units?
TRXF11 — a Brazilian real estate investment trust (FII, the local equivalent of a REIT) — launched its 13th share offering on August 5, 2026. The fund is selling new units at R$ 94.25 each (approximately USD 17 at current rates). If you already hold units, you have a subscription right: priority access to buy your proportional share of the new units before outside investors. If you don't act, your ownership stake in the fund shrinks.
The short version: TRXF11 wants to raise up to R$ 5 billion (potentially R$ 10 billion if the additional tranche is fully exercised) to pay for properties it has been acquiring. Between August 13 and 26, existing unitholders decide whether to subscribe — and maintain their proportional weight — or stand aside and accept dilution.
Key numbers for TRXF11's 13th share offering
This offering uses a best-efforts structure: the lead coordinator (BTG Pactual Investment Banking) commits to selling as many units as possible, but doesn't guarantee full placement. This differs from a firm commitment offering, where the bank would buy any unsold units. Partial distribution is allowed: the deal can close with a minimum of 106,000 units (R$ 9,990,500). The offering is restricted to Professional Investors (per CVM Resolution 30, Art. 11), but existing unitholders — regardless of classification — hold the subscription rights.
How subscription rights work and how many units you can buy
When a fund issues new units, existing holders get first right of refusal in proportion to their current stake. This mechanism protects you from involuntary dilution: by exercising your rights, you maintain the same relative weight in the fund as before.
The exact entitlement is set by the subscription ratio, which for this offering is 0.84974854199. Multiply your current unit count by this number and round down (only whole units can be subscribed).
Example — if you hold 1,000 units:
1,000 × 0.84974854199 = 849.74 → you can subscribe up to 849 new units.
Total cost to exercise in full: 849 × R$ 94.39 = R$ 80,137.11 (using the subscription price including the distribution fee).
In other words: maintaining your proportional stake on 1,000 units requires investing roughly R$ 80,000 more.
There is also an oversubscription right: if you exercise your primary subscription, you can request additional units that other unitholders chose not to take. These are allocated on a pro-rata basis during a separate oversubscription window.
Why the issue price is higher than the market price
The TRXF11 unit trades at R$ 89.43 on the exchange, yet new units are being offered at R$ 94.25 — about 5.4% above the screen price. This seems counterintuitive at first glance.
The issue price was derived from the fund's net asset value (NAV) per unit as of June 30, 2026 (R$ 95.75), minus the dividend paid on July 14, 2026 (R$ 1.50): 95.75 − 1.50 = R$ 94.25. The rationale is to issue at book value rather than at the prevailing discount, so existing holders don't sell a piece of the fund below what it's actually worth on paper.
The practical implication: the fund currently trades at a price-to-NAV of 0.93, meaning the market values it at 7% below book. Subscribing at R$ 94.25 costs more than buying the same unit on the exchange at R$ 89.43. That gap is a measurable, objective data point — each unitholder weighs it individually against the strategic rationale for participating.
What is the add-on tranche and why the issue could double
The base offering covers up to 53,050,398 units (R$ 5 billion). An add-on tranche of 100% on top of that allows the fund to issue up to 106,100,796 units in total — R$ 10 billion. The add-on is only activated if demand warrants it. This is a common mechanism: it leaves the door open for more capital without launching a separate offering.
To put it in perspective: TRXF11 currently has 62,454,308 units outstanding. If just the base offering is fully subscribed, unit count rises by +85%. If the entire add-on tranche is used as well, it rises by +170%. For a fund of its current size, this is a very large issuance — which is precisely why dilution is the central topic here.
Offering timeline — dates that matter
| Event | Date |
|---|---|
| Record date for subscription rights (market close) | Aug 10, 2026 |
| Subscription rights exercise window (B3) | Aug 13–26, 2026 |
| Rights exercise closes (registrar) | Aug 26, 2026 |
| Rights settlement | Aug 26, 2026 |
| Oversubscription period | Aug 28 – Sep 2, 2026 |
| Oversubscription settlement | Sep 10, 2026 |
| General subscription period (B3) | Sep 10–24, 2026 |
| General settlement (B3) | Sep 30, 2026 |
| Maximum offer closing date | Jan 27, 2027 |
Subscription receipts issued during the offering only convert into freely tradeable units after the fund publishes the closing notice and receives B3 authorization. Between subscribing and holding a liquid unit there is a waiting period — you hold a receipt, not the final security.
What the R$ 5–10 billion will fund
According to the regulatory filing, proceeds will go toward built-to-suit (BTS) and sale-and-leaseback (SLB) assets already announced or recently acquired. Two concrete commitments stand out:
- Guarulhos logistics complex / Mercado Livre: R$ 1.435 billion acquisition, payable in four semi-annual installments.
- Cy.Capital memorandum of understanding: a non-binding MoU for R$ 2.13 billion covering five assets, still subject to Brazilian antitrust approval (CADE).
In short, the rights offering is the funding mechanism for TRXF11's expansion. The fund's model centers on long-term atypical leases (79.4% of revenue, average contract life of 13 years) with blue-chip tenants — Mercado Livre (18% of revenue), Assaí (16.4%), and Grupo Pão de Açúcar/PCAR3 (7.8%). Scaling that model through BTS and SLB acquisitions is the core strategy; this issuance is how that growth is financed.
What unitholders face as a decision
The concrete choice before unitholders by August 26 is: exercise or not exercise. Each path has a mechanical consequence:
- Full exercise: buy 0.84974854 new units per unit held at R$ 94.39 and preserve your proportional weight. Requires new capital — about R$ 80,000 for 1,000 units.
- Partial exercise: subscribe fewer than your full entitlement; dilute proportionally to the unexercised portion.
- No exercise: no new cash outlay, but your relative stake shrinks as new units are issued to others.
- Sell the right: in many Brazilian FII offerings, subscription rights trade on the B3 exchange during the rights window — check with your broker whether there is liquidity in this specific right.
To gauge the NAV impact: if the base offering is fully subscribed at R$ 94.25, the NAV per unit drops from R$ 95.75 to approximately R$ 95.07, a decline of about 0.71%. The issue price is close to book value, so the per-unit NAV hit is modest. What changes meaningfully is the relative weight of any holder who does not participate.
Dilution note for non-subscribers. If the base offering is 100% placed, the current 62,454,308 units will represent 62,454,308 / (62,454,308 + 53,050,398) ≈ 54.1% of the expanded total. A holder who subscribes nothing sees their relative stake fall to roughly 54% of what it was. If the full add-on tranche is used (+170% more units), the dilution for passive holders is even greater. This affects voting weight and ownership share — not the market price of the individual unit, which is set by trading.
Why we lowered TRXF11's score from 8.5 to 8.0. This issuance confirms that the recent acquisitions (Guarulhos, Cy.Capital MoU) will be funded through dilution of up to +170%. That is the fund's growth model — it's a feature, not a flaw — but it creates short-term pressure for holders who cannot or choose not to add more capital. With Brazil's benchmark rate (Selic) at 14.25% p.a., the opportunity cost of committing another ~R$ 80,000 at an above-market issue price is real. Current score: 8.0/10, verdict: BUY.
What to track going forward
This offering is live, with open decisions and deadlines ahead. Key items to monitor:
- Aug 10, 2026 — record date. You must be a unitholder at market close to hold subscription rights.
- Aug 13–26 — window to exercise rights (and, if your broker supports it, to trade the right on B3).
- Aug 28 – Sep 2 — oversubscription period for those who exercised and want additional units.
- CADE approval — the Cy.Capital MoU is non-binding and contingent on Brazilian antitrust clearance; watch whether that deal actually closes.
- Final placement amount — best-efforts with partial distribution means the final raise could land anywhere between the R$ 9.99 million minimum and R$ 10 billion maximum. This determines how much of the acquisition pipeline is funded by the offering.
- Jan 27, 2027 — maximum offer closing date, after which subscription receipts convert to freely tradeable units.
The decision to subscribe or not depends on your available capital, time horizon, and conviction on the fund's growth trajectory. This article provides the facts, numbers, and timeline; the judgment call is yours.
